Boston Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Boston Advisors's CL Position: Q3 2019 in Review
Boston Advisors reduced its Colgate-Palmolive (CL) stake by 8.1% in Q3 2019, selling an estimated $521K and leaving 81,871 shares worth $6.02M. The position accounts for 0.31% of the portfolio, ranked #89.
Boston Advisors first reported a position in CL in Q2 2013 and has held it in 26 quarters since. The position peaked at $44.2M in Q1 2016. 1,446 funds tracked by Wall St. Rank hold CL as of Q3 2019.
- Boston Advisors held 81,871 shares of Colgate-Palmolive worth $6.02M as of Q3 2019.
- Boston Advisors sold 7,187 Colgate-Palmolive shares in Q3 2019, an estimated $521K.
- Colgate-Palmolive made up 0.31% of Boston Advisors's portfolio in Q3 2019, its #89 holding.
- Boston Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
- Boston Advisors's Colgate-Palmolive position peaked at $44.2M in Q1 2016.
- 1,446 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2019.
Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.